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Introduction
NBEAL2 has been identified as the causative gene in gray platelet 
syndrome (GPS), a rare autosomal recessive disease characterized 
by platelet α-granule deficiency, which manifests clinically with 
thrombocytopenia, agranular platelets, bleeding tendencies, and 
myelofibrosis (1–3). Recent studies have associated Nbeal2 defi-
ciency with abnormal megakaryocyte differentiation, platelet for-
mation, and α-granule biogenesis or retention (4–6). NBEAL2 is a 
member of the BEACH domain–containing protein (BDCP) fami-
ly. BEACH (beige and Chediak-Higashi) is a conserved domain of 
approximately 280 residues found in 9 human BDCPs (7). BDCPs 
are large, multi-domain scaffolding proteins that function through 
unknown mechanisms. A unifying feature of all BDCPs seems to be 
their involvement in membrane fission and fusion events that have 
an impact on granule biogenesis, lysosome function, and autopha-
gy, among other cellular processes (7). Indeed, other BDCPs have 
been implicated in monogenic immunodeficiencies (8–11).
Of the known GPS patients, 31 have mutations in NBEAL2. 
Four of these patients show evidence of abnormal susceptibility to 
infection (12–15), but a lack of comprehensive clinical data means 
this almost certainly represents an underestimate of the prev-
alence of immunological abnormalities in NBEAL2 deficiency. 
Consistent with this, neutrophil granule abnormalities have been 
described in some patients with GPS (12, 16). We therefore used 
an Nbeal2-deficient mouse (4) to investigate the role of NBEAL2 
in immunity.
Results and Discussion
Using public RNA expression libraries, we found that Nbeal2 is 
expressed highly in the immune system (Supplemental Figure 1A; 
supplemental material available online with this article; https://
doi.org/10.1172/JCI91684DS1). Within the human and mouse 
immune systems, Nbeal2 is expressed most highly in neutrophils 
and NK cells, which, like platelets, are highly dependent on granule 
exocytosis for their normal function (Supplemental Figure 1, B and 
C). We therefore examined the granulocytes of Nbeal2-KO mice 
and observed by flow cytometry reduced side-scatter in Nbeal2–/– 
neutrophils (Figure 1A). Mixed BM–chimeric mice showed that 
this observation was neutrophil intrinsic (Supplemental Figure 
2). Low side-scatter was also evident in splenic eosinophils (Sup-
plemental Figure 3A). We found that neutrophil numbers were 
also increased in the BM, blood, and spleens of Nbeal2–/– mice 
(Figure 1B). Consistent with this, we observed a reduction in elec-
tron-dense granules in Nbeal2–/– neutrophils (Figure 1C). Neutro-
phil granules can be divided into 3 types (primary, secondary, and 
tertiary/gelatinase) depending on protein content and the order 
of release and synthesis. CD11b, a secondary granule membrane 
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cient neutrophils, as were secondary granule components such 
as lactoferrin, matrix metalloproteinase 8, and Rab27A (Supple-
mental Table 1). Protein set enrichment analysis of Rab and oth-
er GTPase family members revealed a relative reduction in Rab 
family members (Supplemental Figure 4A), which control many 
critical aspects of vesicle biology. These differences could not be 
accounted for by differences in mRNA expression (Supplemen-
tal Table 2). Protein ontology analysis of proteins downregulat-
ed by 2.5-fold (log
2
) in Nbeal2–/– neutrophils revealed significant 
enrichment of granule- and vesicle-associated protein terms 
(Supplemental Table 3). To confirm that the downregulated 
proteins were enriched for granule components, we performed 
protein set enrichment analysis using lists of proteins identified 
in human neutrophil granule subsets (18). We found significant 
enrichment of granule (primary, secondary, and gelatinase) and 
component, was increased on the surface of Nbeal2–/– BM neutro-
phils, suggesting a dysregulation of granule exocytosis (Supple-
mental Figure 3B). These findings were consistent with previous 
observations in human GPS neutrophils showing reduced gran-
ularity via electron microscopy and higher CD11b expression on 
neutrophils from members of a GPS-affected family (12, 17).
We next assessed whether a lack of visible granules in 
Nbeal2–/– neutrophils corresponded with deficiency, rather than 
mislocalization, of granule proteins by assessing the whole 
neutrophil proteome using label-free mass spectrometry (MS) 
(Figure 1D). We found that 1,290 proteins were differentially 
expressed between Nbeal2+/+ and Nbeal2–/– neutrophils (Sup-
plemental Table 1). Many major primary granule components, 
including myeloperoxidase, elastase, proteinase 3, cathepsin G, 
and CD63 were detected at much lower levels in Nbeal2-defi-
Figure 1. Immunophenotyping shows reduced granularity in Nbeal2–/– granulocytes. (A) Flow plots of BM neutrophils showing forward scatter (FSC) and 
side scatter (SSC), together with the geometric mean of SSC in Gr-1hiCD11b+ neutrophils from BM, blood, and spleen (n = 6–7). (B) Proportion of neutrophils 
in the BM, blood, and spleen and absolute numbers of splenic neutrophils (n = 6–7). (C) Transmission electron micrographs of BM neutrophils from whole 
BM sections. Representative images of neutrophils (top) (original magnification, ×3,500) and a section from the image (bottom) (original magnification, 
×6,500). Scale bars: 500 nm (all images). Electron-dense granules (arrowheads) were counted by an investigator blinded to genotype for the WT cells 
(n = 13) and Nbeal2–/– cells (n = 23) across 3 biological replicates. (D) Volcano plot shows the 3,485 proteins identified in the BM neutrophil proteome of 
Nbeal2+/+ and Nbeal2–/– mice. The y axis shows FDR-corrected P values, the x axis displays the fold change (log
2
) of Nbeal2+/+ protein expression compared 
with Nbeal2–/– expression, and the horizontal line shows the cutoff at P = 0.05. Granule components, NADPH oxidase subunits, and Nbeal2 are indicated in 
red. Error bars indicate the mean and SD. Data are representative of 2 independent experiments (A and B) or a pooled analysis from 3 independent MS runs 
(D). *P < 0.05, **P < 0.01, and ***P < 0.001, by Kruskal-Wallis (A and B) and Mann-Whitney U (C) tests.
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Nbeal2-deficient neutrophils generated increased ROS in 
response to soluble ROS-inducing agonists, such as fMLP and 
PMA, or opsonized particulate zymosan, whether detected by che-
miluminescent luminol (Figure 2, B–D) or lucigenin (Supplemental 
Figure 5D). Several factors may contribute to this enhanced phago-
cyte respiratory burst. First, generation of superoxide is enhanced 
in the absence of MPO, which is only expressed at very low levels 
in Nbeal2–/– mice (Supplemental Figure 5B) (20). Neutrophils treat-
ed with chemical inhibitors of MPO or those from MPO-deficient 
individuals produce increased superoxide in response to several 
stimuli (21). Second, increasing the availability of cytoplasmic 
subunits such as p47 and p67 increases the generation of ROS (22, 
23), and we found these subunits to be increased in NBEAL2 defi-
ciency. Third, an increased oxidative burst could, in theory, result 
from abnormal localization of the membrane-bound Gp91phox and 
p22phox that might occur in the absence of secondary granules in 
Nbeal2–/– neutrophils.
Given the granule deficiency of Nbeal2–/– neutrophils and 
that case reports have identified an altered neutrophil phenotype 
and recurrent infections in humans with NBEAL2 deficiency, 
we investigated whether Nbeal2-deficient mice have increased 
cell membrane proteins within Nbeal2+/+ versus Nbeal2–/– neu-
trophils (Supplemental Figure 4), consistent with the absence of 
multiple granule subsets in the latter.
Consistent with these granule defects, Nbeal2-deficient neu-
trophils released negligible amounts of the primary granule com-
ponent elastase extracellularly following stimulation with cytocha-
lasin B and formyl-methionyl-leucyl-phenylalanine (fMLP) (Figure 
2A) and had no detectable neutrophil elastase by confocal micros-
copy or Western blotting (Supplemental Figure 5, A and B). Myelo-
peroxidase (MPO), another major primary granule enzyme, was 
also reduced in Nbeal2–/– neutrophils (Supplemental Figure 5B).
In addition to granule proteins, the production of superoxide 
free radicals by the NADPH oxidase is an important contributor 
to the antimicrobial action of neutrophils. Gp91phox (CYBB), a 
membrane-bound component of the NADPH oxidase known to 
partially localize to secondary granules (19), and the other mem-
brane-bound subunit p22phox (CYBA) were not significantly down-
regulated in Nbeal2–/– neutrophils (Supplemental Table 1). Inter-
estingly, the cytosolic components of the NADPH oxidase (NCF1, 
NCF2, NCF4, and RAC2) were increased in Nbeal2–/– neutrophils 
(Figure 1D, Supplemental Table 1, and Supplemental Figure 5C).
Figure 2. Nbeal2–/– neutrophils have altered effector functions and show susceptibility to S. aureus in vivo. (A) Extracellular elastase release of BM 
neutrophils in response to cytochalasin B (Cyt. B) and fMLP (n = 4). (B–D) BM neutrophils stimulated with fMLP (B), PMA (C), or zymosan (D) and luminol 
cleavage fluorescence were quantified over time and the AUC calculated (n = 3). (E–G) Mice were infected i.v. with the sh100 strain of S. aureus and (E) 
monitored daily for weight changes during the initial 6 days after infection (n = 5–7). (F) Survival curve of mice infected and monitored for 22 days. Mice 
were sacrificed if their weight dropped more than 20% from their starting weight (n = 9–10). (G) Pooled bacterial counts in the kidney, liver, and spleen on 
day 6 after infection from 2 independent experiments (n = 5–7). Data are presented as the mean and SD (A), the mean and SEM (B–E), or the median (G). 
Data are representative of 2 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001, by Mann-Whitney U test (A and G), Kruskal-Wallis test 
(B–D), 2-way ANOVA (E), or log-rank test (F). RLU, relative light units.
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associated with overwhelming sepsis and mortality [ref. 25]), 
comparable to that seen in isotype-treated Nbeal2–/– mice. This 
observation, together with the relative lack of impact of neutro-
phil depletion on Nbeal2–/– mice, suggested that the dominant 
cause of the staphylococcal susceptibility in Nbeal2–/– mice is 
NBEAL2 deficiency in neutrophils (Supplemental Figure 6D).
Given that NK cells also rely on perforin- and granzyme-con-
taining granules to control viral infections, we reasoned that anti-
viral immunity might be affected in Nbeal2–/– mice. The number of 
splenic NK cells was reduced in Nbeal2–/– mice (Figure 3A), with the 
major abnormality being reduced numbers in the mature NK cell 
subset (CD11b+, CD27–) (Figure 3B). We assessed NK cell degran-
ulation in vitro by measuring externalized lysosome-associated 
membrane protein 1 (LAMP-1) following stimulation. Although 
there was no difference in surface LAMP-1 expression at baseline 
or in total LAMP-1 expression (Supplemental Figure 7A), Nbeal2–/– 
NK cells failed to fully upregulate LAMP-1 after PMA and iono-
mycin stimulation (Figure 3C). To investigate whether reduced 
susceptibility to infection in vivo. We first challenged Nbeal2–/– 
mice with Staphylococcus aureus using the sh1000 strain, as neu-
trophils are essential for immunity against this pathogen (24). 
Nbeal2+/+ mice typically experienced a mild illness, but 50% 
to 60% of Nbeal2–/– mice developed weight loss necessitating 
euthanasia within 6 days of infection (Figure 2, E and F). This 
was associated with increased bacterial counts in the kidney and 
liver (Figure 2G) as well as histological evidence of severe uncon-
trolled infection in Nbeal2–/– kidneys, with microabscesses, neu-
trophil infiltrates, acute tubular necrosis, and areas of infarction 
(Supplemental Figure 6A). In vitro, Nbeal2–/– neutrophils showed 
intact phagocytosis of S. aureus, as well as an augmented phago-
cyte respiratory burst against opsonized S. aureus (Supplemental 
Figure 6, B and C). To determine the role of neutrophils in the 
NBEAL2 deficiency pheno type, we compared S. aureus infections 
in neutrophil- depleted Nbeal2+/+ and Nbeal2–/– mice. Depletion of 
neutrophils in Nbeal2+/+ mice led to increased bacterial burden 
in the kidney (a site in which a lack of bacterial control has been 
Figure 3. Nbeal2–/– mice have dysfunctional NK cells in vitro and an impaired response to mCMV in vivo. (A) Proportion and absolute numbers of CD3–
B220–CD49b+NKp46+ splenic NK cells for the indicated genotypes. (B) Expression of CD11b and CD27 (maturation markers) on CD3–B220–NK1.1+NKp46+ NK 
cells. Maturation was measured from gates R1 to R4 (with R4 being the most mature). Shown are the proportions and absolute numbers for each subset 
(n = 5–7). (C) Surface expression of LAMP-1/isotype of splenic NK cells 0 and 2 hours after PMA/ionomycin stimulation. Representative FACS gating and 
LAMP-1 histogram showing isotype control antibody staining (gray area) and LAMP-1 in Nbeal2+/+ (black line) and Nbeal2–/– mice (red line) (n = 4–5). max, 
maximum; MFI, mean fluorescence intensity. (D–F) Nbeal2+/+ or Nbeal2–/– mice were infected (i.p.) with 3 × 104 salivary gland–propagated Smith strain 
mCMV, and BW was monitored for 4 days after infection (D). On day 4, mice were sacrificed, and virus PFU were quantified in the spleen (E) and lungs (F) 
(n = 11). (G) Splenic NK cells were isolated and cultured in 1,000 U IL-2 for 4 days before cytotoxicity (LDH release) was tested on YAC-1 cells (n = 3). Data are 
presented as the mean and SD (A–D), median (E and F), or SEM (G) and are representative of 3 (A, E, and F) or 2 (B, C, and G) independent experiments.  
*P < 0.05, **P < 0.01, and ***P < 0.001, by Kruskal-Wallis test (A), Mann-Whitney U test (B, C, E, and F), or 2-way ANOVA (D and G).
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Statistics. P values were calculated using a 2-tailed Mann-Whitney 
U test, Kruskal-Wallis 1-way ANOVA, 2-way ANOVA, or a log-rank 
test. P values of less than 0.05 were considered statistically significant.
Study approval. All in vivo experiments were performed accord-
ing to the regulations of the UK Home Office Scientific Procedures 
Act (1986). All studies were reviewed and approved by the University 
Biomedical Services via the Named Animal Care and Welfare Officer.
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NK cell numbers and degranulation had in vivo consequences, we 
infected mice with murine CMV (mCMV). Nbeal2–/– mice became 
more unwell than did their Nbeal2+/+ counterparts, with increased 
weight loss after infection (Figure 3D) and with markedly more 
viral PFU in the spleen and lungs on day 4 after infection (Figure 3, 
E and F). This difference was likely due to reduced NK cytotoxicity 
(Figure 3G) and not CD8 killing, which was grossly normal (Supple-
mental Figure 7B). Control of mCMV in the liver has been reported 
to be more dependent on IFN-γ (26), so the unchanged viral PFU 
observed in the livers of Nbeal2–/– mice is consistent with their 
intact NK cell IFN-γ production (Supplemental Figure 7, C and D).
NK cell depletion is known to increase mCMV titers (e.g., ×103 
to ×104 in the spleen; ref. 27), which we confirmed with anti-NK1.1 
treatment (splenic PFU increased by 104; Supplemental Figure 7E). 
The increase in mCMV PFU observed in Nbeal2–/–  mice (approxi-
mately ×101 to ×102 in lung and spleen) was therefore intermediate 
between those seen in Nbeal2+/+ and NK-depleted mice (Figure 3, E 
and F). Consistent with this intermediate phenotype, after weight 
loss over the first 4 days, the BW of Nbeal2–/– mice stabilized, and, 
by day 14 after infection, salivary gland viral loads were the same 
as those in Nbeal2+/+ mice (Supplemental Figure 7F), indicating 
that Nbeal2–/– mice could eventually control infection.
We have demonstrated that Nbeal2 plays an important role 
in immunity, as its absence results in an altered development 
or function of granules in neutrophils and NK cells. The lack of 
Nbeal2 in neutrophils led to a marked downregulation of multiple 
granule proteins and effector molecules. Consistent with the lack 
of MPO and the increase in cytoplasmic components of the phago-
cyte respiratory burst, superoxide production was substantially 
enhanced in Nbeal2–/– neutrophils. Despite enhanced superoxide 
production, Nbeal2–/– mice were more susceptible to S. aureus 
infection, emphasizing the importance of intact granule function 
for defense against Staphylococcus. Degranulation, cytotoxicity, 
and maturation were also disrupted in NK cells, and Nbeal2-defi-
cient mice showed increased susceptibility to mCMV. In summa-
ry, our study defines what to our knowledge is a previously unde-
scribed role for Nbeal2 in immunity. Detailed investigation of the 
immune system in patients with NBEAL2 mutations would extend 
these findings, and there may be benefit in screening for NBEAL2 
in patients with primary immune deficiencies.
Methods
Further information can be found in the supplemental material. See 
complete unedited blots in the supplemental material.
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